Mural Oncology Financials
| MURA Stock | 3.44 0.20 5.49% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.04 | 9.5577 |
|
|
The financial analysis of Mural Oncology is a critical element in measuring its lifeblood. Investors should not minimize Mural Oncology's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Mural |
Please note, the presentation of Mural Oncology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mural Oncology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mural Oncology's management manipulating its earnings.
Mural Oncology Stock Summary
Mural Oncology competes with Puma Biotechnology, Iovance Biotherapeutics, Syndax Pharmaceuticals, and Protagonist Therapeutics. Mural Oncology is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | IE000LK2BOB4 |
| CUSIP | G63365103 |
| Location | Ireland |
| Business Address | 10 Earlsfort Terrace, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.muraloncology.com |
| Phone | 353 1 905 8020 |
Mural Oncology Key Financial Ratios
| Return On Equity | -1.78 | ||||
| EBITDA | (192.72 M) | ||||
| Net Income | (207.45 M) | ||||
| Book Value Per Share | 15.81 X | ||||
| Market Capitalization | 62.1 M |
Mural Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mural Oncology's current stock value. Our valuation model uses many indicators to compare Mural Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mural Oncology competition to find correlations between indicators driving Mural Oncology's intrinsic value. More Info.Mural Oncology plc is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers . At present, Mural Oncology's Return On Equity is projected to drop based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mural Oncology's earnings, one of the primary drivers of an investment's value.Mural Oncology plc Systematic Risk
Mural Oncology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mural Oncology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Mural Oncology plc correlated with the market. If Beta is less than 0 Mural Oncology generally moves in the opposite direction as compared to the market. If Mural Oncology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mural Oncology plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mural Oncology is generally in the same direction as the market. If Beta > 1 Mural Oncology moves generally in the same direction as, but more than the movement of the benchmark.
Mural Oncology December 17, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mural Oncology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mural Oncology plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mural Oncology plc based on widely used predictive technical indicators. In general, we focus on analyzing Mural Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mural Oncology's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.59 | |||
| Information Ratio | 0.0096 | |||
| Maximum Drawdown | 20.93 | |||
| Value At Risk | (5.22) | |||
| Potential Upside | 4.76 |
Complementary Tools for Mural Stock analysis
When running Mural Oncology's price analysis, check to measure Mural Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mural Oncology is operating at the current time. Most of Mural Oncology's value examination focuses on studying past and present price action to predict the probability of Mural Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mural Oncology's price. Additionally, you may evaluate how the addition of Mural Oncology to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |